ATHIRA PHARMA
Live / Registered — Registered (as of 05 Dec 2023)
What this means for you
Registered since 05 Dec 2023. The owner can stop confusingly similar uses in the classes it covers.
Record
- Serial number
- 88361359
- Registration number
- 7236685
- Mark type
- Stylized text
- Filed
- 28 Mar 2019
- Published for opposition
- 08 Sept 2020
- Registered
- 05 Dec 2023
- Attorney of record
- KEVIN S. COSTANZA
Goods and services
- Class 005 — Pharmaceuticals: Prescription pharmaceutical preparations, prescription pharmaceutical compounds in the nature of small molecule chemical compounds, and prescription pharmaceutical compositions for use in the prevention and treatment of neurodegenerative, neurologic, neuropsychiatric and inflammatory disorders such as Alzheimer's Disease, Parkinson's Disease, Multiple Sclerosis, neuropathy and neuropathic pain, Stroke, Depression, Insomnia, Schizophrenia, Hearing Loss and Rheumatoid Arthritis
Owner
- Athira Pharma, Inc., Bothell, WA, US
- Athira Pharma, Inc., Bothell, WA, US
- Athira Pharma, Inc., Seattle, WA, US
Prosecution history
- 05 Dec 2023 — NOTICE OF REGISTRATION CONFIRMATION EMAILED
- 05 Dec 2023 — REGISTERED-PRINCIPAL REGISTER
- 01 Nov 2023 — NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
- 31 Oct 2023 — ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
- 11 May 2023 — APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
- 11 May 2023 — TEAS CHANGE OF CORRESPONDENCE RECEIVED
- 11 May 2023 — TEAS CHANGE OF OWNER ADDRESS RECEIVED
- 10 May 2023 — STATEMENT OF USE PROCESSING COMPLETE
- 20 Apr 2023 — USE AMENDMENT FILED
- 08 May 2023 — CASE ASSIGNED TO INTENT TO USE PARALEGAL
- 20 Apr 2023 — TEAS STATEMENT OF USE RECEIVED
- 18 Apr 2023 — SOU TEAS EXTENSION RECEIVED
- 15 Oct 2022 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 13 Oct 2022 — SOU EXTENSION 4 GRANTED
- 13 Oct 2022 — SOU EXTENSION 4 FILED